Jh. Richardson et al., INTRABODY-MEDIATED KNOCKOUT OF THE HIGH-AFFINITY IL-2 RECEPTOR IN PRIMARY HUMAN T-CELLS USING A BICISTRONIC LENTIVIRUS VECTOR, Gene therapy, 5(5), 1998, pp. 635-644
A bicistronic human immunodeficiency virus type 1 (HIV-1)-based vector
is described in which the expression of a selectable marker and a sec
ond gene of interest are for coupled by means of an internal ribosome
entry site. The vector provides high-level expression of We coselected
gene in approximately 90% of transduced cells and has been used to ex
press an endoplasmic reticulum-targeted antibody (intrabody) directed
against a subunit receptor, IL-2R alpha. In the established T cell lin
e and also in primary human T cells stably transduced with the intrabo
dy vector, the cell surface expression of IL-2R alpha could be reduced
to a low or undetectable level. Responsiveness to IL-2 was reduced 10
-fold in We IL-2R alpha-negative cells, consistent with a lack of high
-affinity IL-2 receptors. Pseudotyping of the HIV-I core with the vesi
cular stomatitis virus G protein improved particle stability by two- t
o three-fold and enhanced vector entry into established T cell lines u
p to 230-fold. Vector entry into primary human T cells was most effici
ent when the amphotropic murine leukemia virus envelope was used. The
forced, high-expression capability of the bicistronic vector, together
with the capacity of HIV-1 vectors to infect nondividing cells, make
this an attractive tool for the genetic manipulation of primary cell t
ypes.